• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自组装核桃蛋白纳米颗粒的增溶机制及其对姜黄素的包埋。

Solubilization mechanism of self-assembled walnut protein nanoparticles and curcumin encapsulation.

机构信息

Department of Food Science and Engineering, College of Biological Sciences and Biotechnology, Beijing Key Laboratory of Forest Food Processing and Safety, Beijing Forestry University, Beijing, China.

Department of Science and Engineering, Hebei Agricultural University, Cangzhou, China.

出版信息

J Sci Food Agric. 2023 Aug 15;103(10):4908-4918. doi: 10.1002/jsfa.12559. Epub 2023 Mar 29.

DOI:10.1002/jsfa.12559
PMID:36929026
Abstract

BACKGROUND

Native walnut protein is an alkali-soluble protein that seriously limits the application of walnut protein. The pH-shifting method could improve the solubility of walnut proteins and enable the encapsulation of active ingredients. The present study aimed to prepare water-soluble nanoparticles of curcumin using walnut protein and evaluate the process of walnut protein self-assembly, interaction between walnut protein and curcumin, encapsulation properties, and stability of nanoparticles.

RESULTS

The solubility of native walnut protein was poor, but the solubility of walnut protein nanoparticles (WPNP) formed by walnut protein after pH-shifting significantly improved to 91.5 ± 1.2%. This is because, during the process of pH changing from 7 to 12 and back to 7, walnut protein first unfolded under alkaline conditions and then refolded under pH drive, finally forming an internal hydrophobic and external hydrophilic shell-core structures. The quenching type of walnut protein and curcumin was static quenching, and the quenching constant was 2.0 × 10  mol  L  s , indicating that the interaction between walnut protein and curcumin was non-covalent. Adding curcumin resulted in the formation of nanoparticles with small particle size compared with the no-load. The loading capacity of curcumin-loaded walnut protein nanoparticles (WPNP-C) was 222 mg g walnut protein isolate. Under the same mass, the curcumin equivalent concentration in aqueous solution of WPNP-C was 17 000 times higher than that of the native curcumin.

CONCLUSION

The solubility of the self-assembled WPNP significantly increased after pH-shifting treatment. The walnut protein carrier could improve the stability of the encapsulated curcumin. Therefore, walnut proteins could be used as water-soluble carriers for hydrophobic drugs. © 2023 Society of Chemical Industry.

摘要

背景

天然核桃蛋白是一种堿溶性蛋白,严重限制了核桃蛋白的应用。pH 值变换法可提高核桃蛋白的溶解度,实现活性成分的包封。本研究旨在利用核桃蛋白制备姜黄素的水溶性纳米粒子,并评价核桃蛋白自组装过程、核桃蛋白与姜黄素之间的相互作用、纳米粒子的包封特性和稳定性。

结果

天然核桃蛋白的溶解度较差,但经 pH 值变换形成的核桃蛋白纳米粒子(WPNP)的溶解度显著提高到 91.5±1.2%。这是因为在 pH 值从 7 变为 12 再变回 7 的过程中,核桃蛋白首先在堿性条件下展开,然后在 pH 驱动下重新折叠,最终形成内部疏水和外部亲水的核壳结构。核桃蛋白和姜黄素的猝灭类型为静态猝灭,猝灭常数为 2.0×10 mol L s ,表明核桃蛋白与姜黄素之间的相互作用是非共价的。加入姜黄素导致形成的纳米粒子比未负载时的粒子尺寸更小。载姜黄素的核桃蛋白纳米粒子(WPNP-C)的载药量为 222mg g 核桃蛋白分离物。在相同质量下,WPNP-C 水溶液中姜黄素的等效浓度比天然姜黄素高 17000 倍。

结论

自组装 WPNP 经 pH 值变换处理后溶解度显著提高。核桃蛋白载体可提高包封姜黄素的稳定性。因此,核桃蛋白可用作疏水性药物的水溶性载体。 © 2023 化学工业协会。

相似文献

1
Solubilization mechanism of self-assembled walnut protein nanoparticles and curcumin encapsulation.自组装核桃蛋白纳米颗粒的增溶机制及其对姜黄素的包埋。
J Sci Food Agric. 2023 Aug 15;103(10):4908-4918. doi: 10.1002/jsfa.12559. Epub 2023 Mar 29.
2
Phosphorylated walnut protein isolate as a nanocarrier for enhanced water solubility and stability of curcumin.磷酸化核桃分离蛋白作为一种纳米载体用于增强姜黄素的水溶性和稳定性。
J Sci Food Agric. 2022 Oct;102(13):5700-5710. doi: 10.1002/jsfa.11917. Epub 2022 Apr 23.
3
Self-assembled pea vicilin nanoparticles as nanocarriers for improving the antioxidant activity, environmental stability and sustained-release property of curcumin.自组装豌豆伴球蛋白纳米颗粒作为纳米载体用于提高姜黄素的抗氧化活性、环境稳定性和缓释性能。
J Sci Food Agric. 2024 Mar 15;104(4):2467-2476. doi: 10.1002/jsfa.13132. Epub 2023 Nov 30.
4
pH - Responsive colloidal carriers assembled from β-lactoglobulin and Epsilon poly-L-lysine for oral drug delivery.由β-乳球蛋白和 ε-聚赖氨酸组装的 pH 响应胶体载体用于口服药物传递。
J Colloid Interface Sci. 2021 May;589:45-55. doi: 10.1016/j.jcis.2020.12.054. Epub 2020 Dec 21.
5
One-step self-assembly of curcumin-loaded zein/sophorolipid nanoparticles: physicochemical stability, redispersibility, solubility and bioaccessibility.载姜黄素的玉米醇溶蛋白/槐糖脂纳米粒子的一步自组装:物理化学稳定性、再分散性、溶解度和生物利用度。
Food Funct. 2021 Jul 5;12(13):5719-5730. doi: 10.1039/d1fo00942g.
6
Improving curcumin solubility and bioavailability by encapsulation in saponin-coated curcumin nanoparticles prepared using a simple pH-driven loading method.通过使用简单的 pH 驱动加载方法将姜黄素包封在皂苷包覆的姜黄素纳米粒子中,提高姜黄素的溶解度和生物利用度。
Food Funct. 2018 Mar 1;9(3):1829-1839. doi: 10.1039/c7fo01814b. Epub 2018 Mar 8.
7
Structural interplay between curcumin and soy protein to improve the water-solubility and stability of curcumin.姜黄素与大豆蛋白的结构相互作用,提高姜黄素的水溶性和稳定性。
Int J Biol Macromol. 2021 Dec 15;193(Pt B):1471-1480. doi: 10.1016/j.ijbiomac.2021.10.210. Epub 2021 Nov 3.
8
Mechanism of enhancing the water-solubility and stability of curcumin by using self-assembled cod protein nanoparticles at an alkaline pH.在碱性pH条件下利用自组装鳕鱼蛋白纳米颗粒提高姜黄素水溶性和稳定性的机制
Food Funct. 2021 Dec 13;12(24):12696-12705. doi: 10.1039/d1fo02833b.
9
Novel Soy β-Conglycinin Core-Shell Nanoparticles As Outstanding Ecofriendly Nanocarriers for Curcumin.新型大豆β-伴球蛋白核壳纳米粒子作为姜黄素的杰出环保型纳米载体。
J Agric Food Chem. 2019 Jun 5;67(22):6292-6301. doi: 10.1021/acs.jafc.8b05822. Epub 2019 May 28.
10
pH-driven preparation of pea protein isolate-curcumin nanoparticles effectively enhances antitumor activity.pH驱动制备豌豆分离蛋白-姜黄素纳米颗粒可有效增强抗肿瘤活性。
Int J Biol Macromol. 2024 Jan;256(Pt 1):128383. doi: 10.1016/j.ijbiomac.2023.128383. Epub 2023 Nov 22.

引用本文的文献

1
Pharmacological effects, formulations, and clinical research progress of curcumin.姜黄素的药理作用、制剂及临床研究进展
Front Pharmacol. 2025 Mar 17;16:1509045. doi: 10.3389/fphar.2025.1509045. eCollection 2025.